Showing results (71-80 of 101) with videos related to
Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|July 5, 2015
Structure activity relationship of pyridoxazinone substituted RHS analogs of oxabicyclooctane-linked 1,5-naphthyridinyl novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-6)Sheo B Singh, David E Kaelin, Jin Wu, et al.Bioorganic & Medicinal Chemistry Letters|February 15, 2002
A combinatorial library of indinavir analogues and its in vitro and in vivo studiesYuan Cheng, Thomas A Rano, Tracy T Huening, et al.Bioorganic & Medicinal Chemistry Letters|April 26, 2015
Structure activity relationship of substituted 1,5-naphthyridine analogs of oxabicyclooctane-linked novel bacterial topoisomerase inhibitors as broad-spectrum antibacterial agents (Part-4)Sheo B Singh, David E Kaelin, Jin Wu, et al.Chemistry & Biology|October 13, 2015
Elucidation of DnaE as the Antibacterial Target of the Natural Product, NargenicinRonald E Painter, Gregory C Adam, Marta Arocho, et al.Chemmedchem|October 16, 2013
Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activityCraig A Coburn, Peter T Meinke, Wei Chang, et al.Journal of the American Chemical Society|March 15, 2008
Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A proteaseNigel J Liverton, M Katharine Holloway, John A McCauley, et al.ACS Medicinal Chemistry Letters|November 17, 2022
The Invention of WM382, a Highly Potent PMIX/X Dual Inhibitor toward the Treatment of MalariaManuel de Lera Ruiz, Paola Favuzza, Zhuyan Guo, et al.Microbiology Spectrum|February 23, 2024
Orally available nucleoside analog UMM-766 provides protection in a murine model of orthopox diseaseRajini R Mudhasani, Joseph W Golden, Gregory C Adam, et al.Plos Pathogens|September 7, 2012
Human monoclonal antibody HCV1 effectively prevents and treats HCV infection in chimpanzeesTrevor J Morin, Teresa J Broering, Brett A Leav, et al.Journal of Medicinal Chemistry|April 16, 2004
Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymeraseAnne B Eldrup, Charles R Allerson, C Frank Bennett, et al.Pageof 11